Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Research & Development: 2009-2011

Historic Research & Development for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $91.8 million.

  • Lexicon Pharmaceuticals' Research & Development rose 53.99% to $28.1 million in Q4 2011 from the same period last year, while for Dec 2011 it was $91.8 million, marking a year-over-year increase of 16.95%. This contributed to the annual value of $91.8 million for FY2011, which is 16.95% up from last year.
  • Lexicon Pharmaceuticals' Research & Development amounted to $91.8 million in FY2011, which was up 16.95% from $78.5 million recorded in FY2010.
  • Lexicon Pharmaceuticals' Research & Development's 5-year high stood at $91.8 million during FY2011, with a 5-year trough of $78.5 million in FY2010.
  • For the 3-year period, Lexicon Pharmaceuticals' Research & Development averaged around $83.9 million, with its median value being $81.2 million (2009).
  • In the last 5 years, Lexicon Pharmaceuticals' Research & Development declined by 3.35% in 2010 and then increased by 16.95% in 2011.
  • Over the past 3 years, Lexicon Pharmaceuticals' Research & Development (Yearly) stood at $81.2 million in 2009, then decreased by 3.35% to $78.5 million in 2010, then increased by 16.95% to $91.8 million in 2011.